Valuation: Genpharmasec Limited

Market Cap 43Cr 45.68L 39.98L 36.91L 34.43L 64.87L 66.03L 4.43Cr 1.72Cr 21Cr 1.72Cr 1.68Cr 74Cr P/E 2024
-545x
P/E 2025 94.5x
Enterprise Value 42Cr 44.68L 39.11L 36.11L 33.68L 63.46L 64.59L 4.33Cr 1.68Cr 21Cr 1.68Cr 1.64Cr 73Cr EV / Sales 2024
3.47x
EV / Sales 2025 2.96x
Free-Float
55.34%
Yield 2024 *
-
Yield 2025 -
1 day-0.90%
1 week-0.90%
1 month-7.56%
3 months+41.03%
6 months-16.03%
Current year-16.03%
1 week 1.03
Extreme 1.03
1.14
1 month 1.03
Extreme 1.03
1.22
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
2.2
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
12.4
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 38 01/11/2022
Compliance Officer - 27/03/2024
Director TitleAgeSince
Director/Board Member 57 02/01/2019
Director/Board Member 58 02/01/2019
Director/Board Member - 01/11/2022
Change 5-day change 1-year change 3-year change Capi.($)
+1.82%-0.90%-46.34%-68.75% 65.01L
-2.12%+0.23%-33.28%-16.77% 16TCr
-3.34%-2.98%-10.26%-11.20% 10TCr
+0.47%+0.67%-5.63%+47.06% 5.48TCr
-1.16%-2.66%+54.05%+48.22% 5.33TCr
-2.49%+5.15%-12.15%-42.68% 4.28TCr
-0.43%+11.73% - - 3.35TCr
-3.76%-2.28%-22.84%-47.59% 2.7TCr
+1.22%+6.72%+64.08%-6.14% 2.51TCr
-1.25%+3.62%-12.34%-6.41% 2.08TCr
Average -1.38%+2.44%-2.75%-11.58% 5.22TCr
Weighted average by Cap. -1.80%+1.11%-7.47%-4.33%

Financials

2024 2025
Net sales 30Cr 32.16L 28.15L 25.98L 24.24L 45.67L 46.48L 3.12Cr 1.21Cr 15Cr 1.21Cr 1.18Cr 52Cr 34Cr 35.66L 31.22L 28.82L 26.88L 50.65L 51.55L 3.46Cr 1.34Cr 17Cr 1.34Cr 1.31Cr 58Cr
Net income -12.57L -13.29T -11.64T -10.74T -10.02T -18.88T -19.22T -1L -50.02T -6L -49.95T -48.83T -21.61L 1.23Cr 1L 1L 1L 98.14T 2L 2L 12.62L 5L 60.76L 5L 5L 2.12Cr
Net Debt -18Cr -18.92L -16.56L -15.29L -14.26L -26.87L -27.35L -1.83Cr -71.18L -8.83Cr -71.07L -69.49L -31Cr -94.03L -99.45T -87.05T -80.35T -74.95T -1L -1L -10L -4L -46.4L -4L -4L -1.62Cr
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
10
Date Price Change Volume
01/26/01 1.120 +1.82% 3,111
30/26/30 ₹1.100 -0.90% 2,29,743
29/26/29 ₹1.110 +2.78% 3,10,922
25/26/25 ₹1.080 -5.26% 3,39,763
24/26/24 ₹1.140 +2.70% 2,51,360
  1. Stock Market
  2. Stocks
  3. ADIRASA Stock